Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-06-21 Purchase |
2022-06-23 4:31 pm |
AN2 Therapeutics Inc. | ANTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
302 | $7.99 | $2,413 | 3,748,389 (Indirect) |
View |
2022-06-16 Purchase |
2022-06-21 4:33 pm |
Wave Life Sciences Ltd. | WVE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
9,480,052 | $2.15 | $20,382,112 | 24,295,665 (Indirect) |
View |
2022-06-13 Purchase |
2022-06-15 4:25 pm |
AN2 Therapeutics Inc. | ANTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
81,424 | $7.951 | $647,402 | 3,748,087 (Indirect) |
View |
2022-05-26 Sale |
2022-05-26 5:09 pm |
Kala Pharmaceuticals Inc. | KALA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
1,005,686 | $0.3636 | $365,667 | 7,039,613 (Indirect) |
View |
2022-05-23 Sale |
2022-05-25 5:17 pm |
Kala Pharmaceuticals Inc. | KALA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
2,829,314 | $0.52622 | $1,488,844 | 8,045,299 (Indirect) |
View |
2022-05-10 Purchase |
2022-05-12 7:06 pm |
PepGen Inc. | PEPG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
3,229,200 | $12 | $38,750,400 | 207,672 (Indirect) |
View |
2022-04-26 Purchase |
2022-04-28 4:32 pm |
Nkarta Inc. | NKTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
2,200,000 | $15 | $33,000,000 | 7,805,129 (Indirect) |
View |
2022-03-29 Purchase |
2022-03-31 4:31 pm |
AN2 Therapeutics Inc. | ANTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
1,666,666 | $15 | $24,999,990 | 415,612 (Indirect) |
View |
2022-03-28 Purchase |
2022-03-30 4:31 pm |
Icosavax Inc. | ICVX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
184,218 | $4.5429 | $836,883 | 5,963,565 (Indirect) |
View |
2022-03-14 Purchase |
2022-03-16 5:10 pm |
Cytek Biosciences Inc. | CTKB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
583,870 | $12.31 | $7,188,926 | 13,381,054 (Indirect) |
View |
2022-03-09 Purchase |
2022-03-11 5:27 pm |
Cytek Biosciences Inc. | CTKB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director |
634,638 | $12.86 | $8,158,671 | 12,797,184 (Indirect) |
View |
2022-03-04 Purchase |
2022-03-08 4:59 pm |
Cytek Biosciences Inc. | CTKB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director |
647,264 | $12.74 | $8,248,255 | 12,162,546 (Indirect) |
View |
2022-02-28 Purchase |
2022-03-02 5:29 pm |
Cytek Biosciences Inc. | CTKB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director |
441,865 | $12.95 | $5,721,951 | 11,515,282 (Indirect) |
View |
2022-02-23 Purchase |
2022-02-25 5:43 pm |
Cytek Biosciences Inc. | CTKB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director |
420,380 | $13.23 | $5,559,664 | 11,073,417 (Indirect) |
View |
2022-02-17 Purchase |
2022-02-22 5:22 pm |
Cytek Biosciences Inc. | CTKB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director |
547,380 | $14.06 | $7,695,707 | 10,653,037 (Indirect) |
View |
2022-02-14 Purchase |
2022-02-16 7:39 pm |
Cytek Biosciences Inc. | CTKB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director |
498,629 | $14.89 | $7,426,825 | 10,105,657 (Indirect) |
View |
2021-09-17 Purchase |
2021-09-20 4:30 pm |
DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
1,400,000 | $17 | $23,800,000 | 786,407 (Indirect) |
View |
2021-09-17 Purchase |
2021-09-17 4:34 pm |
Tyra Biosciences Inc. | TYRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
1,250,000 | $16 | $20,000,000 | 442,721 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-06-21 Option Award |
2022-06-22 5:00 pm |
N/A 2032-06-20 |
Aerovate Therapeutics Inc. | AVTE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
12,500 | $0 | 12,500 (Indirect) |
View |
2022-06-15 Option Award |
2022-06-21 4:30 pm |
N/A 2032-06-14 |
Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
25,000 | $0 | 25,000 (Indirect) |
View |
2022-06-14 Option Award |
2022-06-17 4:30 pm |
N/A 2032-06-13 |
Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
16,911 | $0 | 16,911 (Indirect) |
View |
2022-06-14 Option Award |
2022-06-16 4:30 pm |
N/A 2032-06-13 |
Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
12,500 | $0 | 12,500 (Indirect) |
View |
2022-06-13 Option Award |
2022-06-15 4:30 pm |
N/A 2032-06-12 |
Tyra Biosciences Inc. | TYRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
14,500 | $0 | 14,500 (Indirect) |
View |
2022-06-10 Option Award |
2022-06-14 4:30 pm |
N/A 2032-06-09 |
Icosavax Inc. | ICVX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
27,821 | $0 | 5,991,386 (Indirect) |
View |
2022-06-08 Option Award |
2022-06-10 9:07 pm |
N/A 2032-06-07 |
Nkarta Inc. | NKTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
16,000 | $0 | 16,000 (Indirect) |
View |
2022-06-09 Option Award |
2022-06-10 8:30 pm |
N/A 2032-06-09 |
iTeos Therapeutics Inc. | ITOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
17,538 | $0 | 17,538 (Indirect) |
View |
2022-06-08 Option Award |
2022-06-09 5:30 pm |
N/A 2032-06-07 |
Forma Therapeutics Holdings Inc. | FTMX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
11,250 | $0 | 9,025,651 (Indirect) |
View |
2022-06-07 Option Award |
2022-06-09 5:30 pm |
N/A 2032-06-07 |
Solid Biosciences Inc. | SLDB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
51,000 | $0 | 51,000 (Indirect) |
View |
2022-06-07 Option Award |
2022-06-08 5:30 pm |
N/A 2032-06-06 |
DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
21,250 | $0 | 21,250 (Indirect) |
View |
2022-06-03 Option Award |
2022-06-07 5:31 pm |
N/A 2032-06-02 |
Satsuma Pharmaceuticals Inc. | STSA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
30,000 | $0 | 30,000 (Indirect) |
View |
2022-06-01 Option Award |
2022-06-03 5:30 pm |
N/A 2032-05-31 |
Werewolf Therapeutics Inc. | HOWL | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
11,600 | $0 | 11,600 (Indirect) |
View |
2022-05-16 Option Award |
2022-06-02 4:30 pm |
N/A 2032-05-16 |
89bio Inc. | ETNB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
25,000 | $0 | 25,000 (Indirect) |
View |
2022-05-19 Option Award |
2022-06-01 5:15 pm |
N/A 2032-05-18 |
Eliem Therapeutics Inc. | ELYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
10,000 | $0 | 10,000 (Indirect) |
View |
2022-05-10 Conversion |
2022-05-12 7:06 pm |
N/A N/A |
PepGen Inc. | PEPG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
9,893,754 | $0 | 207,672 (Indirect) |
View |
Ownership(A) |
2022-05-12 6:50 pm |
N/A N/A |
PepGen Inc. | PEPG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
0 | $0 | 2,578,819 (Indirect) |
View |
2022-05-06 Option Award |
2022-05-10 4:31 pm |
N/A 2032-05-05 |
PepGen Inc. | PEPG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
11,667 | $0 | 11,667 (Indirect) |
View |
Ownership |
2022-05-05 9:01 pm |
N/A N/A |
PepGen Inc. | PEPG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
0 | $0 | 4,902,750 (Indirect) |
View |
2022-03-29 Conversion |
2022-03-31 4:31 pm |
N/A N/A |
AN2 Therapeutics Inc. | ANTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
1,999,997 | $0 | 415,612 (Indirect) |
View |
Ownership |
2022-03-24 9:22 pm |
N/A N/A |
AN2 Therapeutics Inc. | ANTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
0 | $0 | 1,999,997 (Indirect) |
View |
2021-09-17 Conversion |
2021-09-20 4:30 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
7,617,822 | $0 | 786,407 (Indirect) |
View |
2021-09-17 Conversion |
2021-09-17 4:34 pm |
N/A N/A |
Tyra Biosciences Inc. | TYRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
8,291,242 | $0 | 442,721 (Indirect) |
View |
Ownership |
2021-09-14 7:32 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
0 | $0 | 3,808,911 (Indirect) |
View |
Ownership |
2021-09-14 7:11 pm |
N/A N/A |
Tyra Biosciences Inc. | TYRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
0 | $0 | 5,986,454 (Indirect) |
View |
2021-08-16 Option Award |
2021-08-18 5:32 pm |
N/A 2026-08-16 |
Wave Life Sciences Ltd. | WVE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
42,000 | $0 | 42,000 (Direct) |
View |